What's Going On With Longeveron Stock?

on MSN ago, source:

Longeveron Inc. (NASDAQ:LGVN) shares are trading higher Monday following insider buys from multiple company executives.

Why Longeveron (LGVN) Stock Exploded Higher Today

on MSN ago, source:

Longeveron Inc (NASDAQ:LGVN) shares traded upwards of 50% Monday after the company announced they submitted paperwork for a ...

Longeveron Inc. (LGVN)

20d ago, source: Yahoo Finance

MIAMI, April 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life ...

Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering

6d ago, source: Stockhouse

MIAMI, April 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing ...

Longeveron Announces Pricing of $5.25 Million Public Offering

16d ago, source: Business Insider

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life ...

Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals

17d ago, source: Business Insider

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO ...

Biomednewsbreaks - Longeveron Inc. (NASDAQ: LGVN) Closes On Multimillion-Dollar Warrant Exercise Offering, Public Offering

5d ago, source:

Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related cond ...

Longeveron Inc Ordinary Shares - Class A

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Biomednewsbreaks - Longeveron Inc. (NASDAQ: LGVN) Closes On Public Offering Valued At Estimated $5.2M

12d ago, source:

Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related cond ...

Longeveron Announces Pricing of $5.25 Million Public Offering

16d ago, source: Yahoo Finance

About Longeveron Inc. Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel ...

Longeveron Inc Ordinary Shares - Class A LGVN

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Longeveron Announces Pricing of $5.25 Million Public Offering

17d ago, source: ADVFN

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions ...